Welcome to the investors section of Adocia

Adocia is a biotechnology company specialized in the development of best-in-class medicines from already approved therapeutic proteins.

Adocia Corporate presentation – January 2020 de adocia

Latest Press Releases

2020/03/12Adocia Announces Full Year 2019 Financial Results
2020/03/05Number of shares and voting rights of ADOCIA as of February 28, 2020

All Press releases

Next events

June 8-11, 2020 BIO International Convention, San Diego, USA - The world's largest global biotechnology partnering event.

All events

ADOCIA uses cookies for the effective operation of the Site and to monitor and analyze the traffic on the Site.
The information collected through cookies is solely and strictly for ADOCIA, in compliance with the regulation applicable to the protection of personal data. They are never transmitted to third-parties.

Financial

Welcome to the investors section of Adocia

SFD 2020: Adocia will be presenting M1 Pram (ADO09) at the occasion of Francophone Diabetes Society Congress in Brussels, Belgium next September, 2020

ATTD 2020: Meet the Adocia team and see the E-Poster on M1Pram (ADO09)!